{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:06:09Z","timestamp":1792717569598,"version":"4.5.0"},"reference-count":132,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.molmed.2014.06.001","type":"journal-article","created":{"date-parts":[[2014,7,6]],"date-time":"2014-07-06T04:15:42Z","timestamp":1404620142000},"page":"449-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":355,"title":["Osteoclasts: more than \u2018bone eaters\u2019"],"prefix":"10.1016","volume":"20","author":[{"given":"Julia F.","family":"Charles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios O.","family":"Aliprantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2014.06.001_bib0005","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/bonekey.2013.215","article-title":"Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit","volume":"3","author":"Sims","year":"2014","journal-title":"Bonekey Rep."},{"key":"10.1016\/j.molmed.2014.06.001_bib0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/bonekey.2013.183","article-title":"Mechanisms of osteoclast-dependent bone formation","volume":"2","author":"Teti","year":"2013","journal-title":"Bonekey Rep."},{"key":"10.1016\/j.molmed.2014.06.001_bib0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2014.06.001_bib0020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrd3705","article-title":"Bench to bedside: elucidation of the OPG\u2013RANK\u2013RANKL pathway and the development of denosumab","volume":"11","author":"Lacey","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2014.06.001_bib0025","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1177\/0022034513500306","article-title":"Advances in the regulation of osteoclasts and osteoclast functions","volume":"92","author":"Boyce","year":"2013","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0030","series-title":"Bone Health and Osteoporosis: A Report of the Surgeon General","author":"US Department of Health and Human Services","year":"2004"},{"key":"10.1016\/j.molmed.2014.06.001_bib0035","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00198-009-0920-3","article-title":"Excess mortality following hip fracture: a systematic epidemiological review","volume":"20","author":"Abrahamsen","year":"2009","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.molmed.2014.06.001_bib0040","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI46262","article-title":"Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection","volume":"121","author":"Jones","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2014.06.001_bib0045","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00439-008-0583-8","article-title":"Advances in osteoclast biology resulting from the study of osteopetrotic mutations","volume":"124","author":"Segovia-Silvestre","year":"2009","journal-title":"Hum. Genet."},{"key":"10.1016\/j.molmed.2014.06.001_bib0050","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ng2076","article-title":"Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL","volume":"39","author":"Sobacchi","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2014.06.001_bib0055","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2013.137","article-title":"Osteopetrosis: genetics, treatment and new insights into osteoclast function","volume":"9","author":"Sobacchi","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.molmed.2014.06.001_bib0060","series-title":"Die normale Resorption des Knochengewebes und ihre Bedeutung die Entstehung der typischen Knochenformen","author":"Kolliker","year":"1873"},{"key":"10.1016\/j.molmed.2014.06.001_bib0065","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0070","doi-asserted-by":"crossref","first-page":"E725","DOI":"10.1073\/pnas.1120735109","article-title":"Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH","volume":"109","author":"Bedi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2014.06.001_bib0075","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/stem.1040","article-title":"Induction of osteogenesis in mesenchymal stem cells by activated monocytes\/macrophages depends on oncostatin M signaling","volume":"30","author":"Guihard","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.molmed.2014.06.001_bib0080","doi-asserted-by":"crossref","first-page":"e12290","DOI":"10.1371\/journal.pone.0012290","article-title":"Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss","volume":"5","author":"Tawfeek","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2014.06.001_bib0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1210\/er.2010-0006","article-title":"Osteoclast activity and subtypes as a function of physiology and pathology \u2013 implications for future treatments of osteoporosis","volume":"32","author":"Henriksen","year":"2011","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.molmed.2014.06.001_bib0090","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.bbadis.2009.05.004","article-title":"Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions","volume":"1792","author":"Everts","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2014.06.001_bib0095","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0100","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nm.2793","article-title":"Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells","volume":"18","author":"Xian","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0105","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nm.3143","article-title":"Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis","volume":"19","author":"Zhen","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0110","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/jbmr.070109","article-title":"Are nonresorbing osteoclasts sources of bone anabolic activity?","volume":"22","author":"Karsdal","year":"2007","journal-title":"J. Bone Mineral Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1542\/peds.93.2.247","article-title":"Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course","volume":"93","author":"Gerritsen","year":"1994","journal-title":"Pediatrics"},{"key":"10.1016\/j.molmed.2014.06.001_bib0120","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jbmr.559","article-title":"RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations","volume":"27","author":"Pangrazio","year":"2012","journal-title":"J. Bone Mineral Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jmg.2005.036673","article-title":"Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment","volume":"43","author":"Del Fattore","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molmed.2014.06.001_bib0130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1083\/jcb.151.2.311","article-title":"Decreased c-Src expression enhances osteoblast differentiation and bone formation","volume":"151","author":"Marzia","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2014.06.001_bib0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bone.2008.08.130","article-title":"Bone density, strength, and formation in adult cathepsin K\u2212\/\u2212 mice","volume":"44","author":"Pennypacker","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2014.06.001_bib0140","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1359\/jbmr.060313","article-title":"Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass","volume":"21","author":"Li","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0145","first-page":"666","article-title":"Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation","volume":"123","author":"Lotinun","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2014.06.001_bib0150","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1359\/JBMR.040514","article-title":"Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone","volume":"19","author":"Dai","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0155","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.micron.2005.06.008","article-title":"Reduced osteoblastic population and defective mineralization in osteopetrotic (op\/op) mice","volume":"36","author":"Sakagami","year":"2005","journal-title":"Micron"},{"key":"10.1016\/j.molmed.2014.06.001_bib0160","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/360741a0","article-title":"Bone and haematopoietic defects in mice lacking c-fos","volume":"360","author":"Wang","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2014.06.001_bib0165","doi-asserted-by":"crossref","first-page":"e3174","DOI":"10.1371\/journal.pone.0003174","article-title":"Cthrc1 is a positive regulator of osteoblastic bone formation","volume":"3","author":"Kimura","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2014.06.001_bib0170","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1172\/JCI69493","article-title":"Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation","volume":"123","author":"Takeshita","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2014.06.001_bib0175","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.2187","article-title":"Osteoclast-derived complement component 3a stimulates osteoblast differentiation","author":"Matsuoka","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0180","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1038\/sj.emboj.7601430","article-title":"Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling","volume":"25","author":"Ryu","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2014.06.001_bib0185","doi-asserted-by":"crossref","first-page":"20764","DOI":"10.1073\/pnas.0805133106","article-title":"Regulation of bone formation by osteoclasts involves Wnt\/BMP signaling and the chemokine sphingosine-1-phosphate","volume":"105","author":"Pederson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2014.06.001_bib0190","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature07713","article-title":"Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis","volume":"458","author":"Ishii","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2014.06.001_bib0195","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1084\/jem.20101474","article-title":"Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo","volume":"207","author":"Ishii","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0200","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4161\/cam.20888","article-title":"Bone cell interactions through Eph\/ephrin: bone modeling, remodeling and associated diseases","volume":"6","author":"Matsuo","year":"2012","journal-title":"Cell Adh. Migr."},{"key":"10.1016\/j.molmed.2014.06.001_bib0205","doi-asserted-by":"crossref","first-page":"14637","DOI":"10.1074\/jbc.M807598200","article-title":"Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis","volume":"284","author":"Irie","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2014.06.001_bib0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cmet.2006.05.012","article-title":"Bidirectional ephrinB2\u2013EphB4 signaling controls bone homeostasis","volume":"4","author":"Zhao","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2014.06.001_bib0215","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1074\/jbc.M112.426080","article-title":"Stimulation of bone formation in cortical bone of mice treated with a receptor activator of nuclear factor-kappaB ligand (RANKL)-binding peptide that possesses osteoclastogenesis inhibitory activity","volume":"288","author":"Furuya","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2014.06.001_bib0220","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/rheumatology\/ken454","article-title":"The National Osteoporosis Guideline Group's new guidelines: what is new?","volume":"48","author":"Bukhari","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.molmed.2014.06.001_bib0225","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bone.2010.11.008","article-title":"Biochemical and molecular mechanisms of action of bisphosphonates","volume":"49","author":"Rogers","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2014.06.001_bib0230","doi-asserted-by":"crossref","first-page":"28164","DOI":"10.1074\/jbc.M110.101964","article-title":"Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL","volume":"285","author":"Pierroz","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2014.06.001_bib0235","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0240","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","article-title":"The effects of parathyroid hormone, alendronate, or both in men with osteoporosis","volume":"349","author":"Finkelstein","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0245","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/jbmr.238","article-title":"Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis","volume":"26","author":"Cosman","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0250","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(13)60856-9","article-title":"Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial","volume":"382","author":"Tsai","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2014.06.001_bib0255","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1479-5876-11-303","article-title":"Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years?","volume":"11","author":"Xu","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0260","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.2211","article-title":"Inhibition of cathepsin K increases modeling-based bone formation, and improves cortical dimension and strength in adult ovariectomized monkeys","author":"Pennypacker","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0265","doi-asserted-by":"crossref","first-page":"29809","DOI":"10.1074\/jbc.M113.485938","article-title":"Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes","volume":"288","author":"Rhee","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2014.06.001_bib0270","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/jbmr.1695","article-title":"Odanacatib in the treatment of postmenopausal women with low bone mineral density: five years of continued therapy in a phase 2 study","volume":"27","author":"Langdahl","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0275","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jbmr.1477","article-title":"Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey","volume":"27","author":"Cusick","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0280","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.bone.2008.05.010","article-title":"The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice","volume":"44","author":"Yamane","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2014.06.001_bib0285","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0290","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1002\/jbmr.474","article-title":"Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover","volume":"26","author":"van Lierop","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0295","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2741\/3673","article-title":"Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals","volume":"16","author":"Takahashi","year":"2011","journal-title":"Front. Biosci."},{"key":"10.1016\/j.molmed.2014.06.001_bib0300","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/1471-2407-10-462","article-title":"Bisphosphonate treatment of aggressive primary, recurrent and metastatic giant cell tumour of bone","volume":"10","author":"Balke","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.molmed.2014.06.001_bib0305","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bone.2007.08.038","article-title":"Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case\u2013control study","volume":"42","author":"Tse","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2014.06.001_bib0310","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1470-2045(10)70010-3","article-title":"Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study","volume":"11","author":"Thomas","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.molmed.2014.06.001_bib0315","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-12-0578","article-title":"Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone","volume":"18","author":"Branstetter","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0320","doi-asserted-by":"crossref","first-page":"e64539","DOI":"10.1371\/journal.pone.0064539","article-title":"Fibrous dysplasia in a 120,000+ year old Neandertal from Krapina, Croatia","volume":"8","author":"Monge","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2014.06.001_bib0325","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5858\/arpa.2012.0013-RS","article-title":"Fibrous dysplasia","volume":"137","author":"Riddle","year":"2013","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-010-0465-9","article-title":"Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm","volume":"68","author":"Vilardaga","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.molmed.2014.06.001_bib0335","doi-asserted-by":"crossref","first-page":"20101","DOI":"10.1073\/pnas.1114656108","article-title":"Wnt\/beta-catenin signaling is differentially regulated by Galpha proteins and contributes to fibrous dysplasia","volume":"108","author":"Regard","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2014.06.001_bib0340","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S8756-3282(03)00064-4","article-title":"Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression","volume":"33","author":"Riminucci","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2014.06.001_bib0345","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI118773","article-title":"Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune\u2013Albright syndrome","volume":"98","author":"Yamamoto","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2014.06.001_bib0350","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00223-013-9829-0","article-title":"Clinical and radiological observations in a case series of 26 patients with fibrous dysplasia","volume":"94","author":"Thomsen","year":"2014","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.molmed.2014.06.001_bib0355","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbmr.1603","article-title":"Denosumab treatment for fibrous dysplasia","volume":"27","author":"Boyce","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0360","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00198-013-2585-1","article-title":"Rapid biochemical response to denosumab in fibrous dysplasia of bone: report of two cases","volume":"25","author":"Ganda","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.molmed.2014.06.001_bib0365","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9440(10)63798-4","article-title":"Genotype\u2013phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis","volume":"162","author":"Taranta","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2014.06.001_bib0370","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0375","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.2353\/ajpath.2009.081026","article-title":"Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH\/PTHrP receptor","volume":"174","author":"Ohishi","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2014.06.001_bib0380","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12984","article-title":"The bone marrow niche for haematopoietic stem cells","volume":"505","author":"Morrison","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2014.06.001_bib0385","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1084\/jem.20110994","article-title":"Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow","volume":"209","author":"Mansour","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0390","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/jcb.24801","article-title":"Altered hematopoietic stem cell and osteoclast precursor frequency in cathepsin K null mice","volume":"115","author":"Jacome-Galarza","year":"2014","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.molmed.2014.06.001_bib0395","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood-2010-05-282855","article-title":"Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo","volume":"117","author":"Lymperi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2014.06.001_bib0400","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3324\/haematol.2013.089466","article-title":"Osteoclasts are not crucial for hematopoietic stem cell maintenance in adult mice","volume":"98","author":"Flores","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2014.06.001_bib0405","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1084\/jem.20101890","article-title":"Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization","volume":"208","author":"Miyamoto","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0410","series-title":"StemBook","article-title":"Egress and mobilization of hematopoietic stem and progenitor cells: a dynamic multi-facet process","author":"Lapid","year":"2008"},{"key":"10.1016\/j.molmed.2014.06.001_bib0415","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1073\/pnas.94.5.1908","article-title":"Cyclophosphamide\/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization","volume":"94","author":"Morrison","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2014.06.001_bib0420","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MOH.0b013e328338b7d5","article-title":"Update on clinical experience with AMD3100, an SDF-1\/CXCL12\u2013CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells","volume":"17","author":"Pusic","year":"2010","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.molmed.2014.06.001_bib0425","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3816\/SCT.2006.n.020","article-title":"The Severe Chronic Neutropenia International Registry: 10-year follow-up report","volume":"3","author":"Dale","year":"2006","journal-title":"Support. Cancer Ther."},{"key":"10.1016\/j.molmed.2014.06.001_bib0430","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.mph.0000210409.48877.c3","article-title":"Osteoporosis in children with severe congenital neutropenia: bone mineral density and treatment with bisphosphonates","volume":"28","author":"Borzutzky","year":"2006","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.molmed.2014.06.001_bib0435","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/jcp.24246","article-title":"A pivotal role of bone remodeling in granulocyte colony stimulating factor induced hematopoietic stem\/progenitor cells mobilization","volume":"228","author":"Li","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.molmed.2014.06.001_bib0440","first-page":"827","article-title":"Overexpression of the granulocyte colony-stimulating factor gene leads to osteoporosis in mice","volume":"74","author":"Takahashi","year":"1996","journal-title":"Lab. Invest."},{"key":"10.1016\/j.molmed.2014.06.001_bib0445","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1182\/blood.V92.9.3465","article-title":"Osteoclast-mediated bone resorption is stimulated during short-term administration of granulocyte colony-stimulating factor but is not responsible for hematopoietic progenitor cell mobilization","volume":"92","author":"Takamatsu","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2014.06.001_bib0450","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nm1417","article-title":"Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells","volume":"12","author":"Kollet","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0455","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1172\/JCI64060","article-title":"The nucleotide sugar UDP-glucose mobilizes long-term repopulating primitive hematopoietic cells","volume":"123","author":"Kook","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2014.06.001_bib0460","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.clinbiochem.2013.04.012","article-title":"The development and characterization of an ELISA specifically detecting the active form of cathepsin K","volume":"46","author":"Sun","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.molmed.2014.06.001_bib0465","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.maturitas.2009.09.011","article-title":"Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate","volume":"64","author":"Munoz-Torres","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.molmed.2014.06.001_bib0470","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1084\/jem.156.5.1516","article-title":"Hematological characterization of congenital osteopetrosis in op\/op mouse. Possible mechanism for abnormal macrophage differentiation","volume":"156","author":"Wiktor-Jedrzejczak","year":"1982","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0475","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5312\/wjo.v3.i9.142","article-title":"RANKL\u2013RANK interaction in immune regulatory systems","volume":"3","author":"Akiyama","year":"2012","journal-title":"World J. Orthop."},{"key":"10.1016\/j.molmed.2014.06.001_bib0480","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/ni.2352","article-title":"The Ets transcription factor Spi-B is essential for the differentiation of intestinal microfold cells","volume":"13","author":"Kanaya","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2014.06.001_bib0485","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nm.3084","article-title":"Blockade of receptor activator of nuclear factor-kappaB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus","volume":"19","author":"Kiechl","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0490","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2014.01.002","article-title":"RANKL\/RANK \u2013 from bone physiology to breast cancer","volume":"25","author":"Sigl","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.molmed.2014.06.001_bib0495","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1359\/JBMR.051007","article-title":"Identification of multiple osteoclast precursor populations in murine bone marrow","volume":"21","author":"Jacquin","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0500","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1172\/JCI60920","article-title":"Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function","volume":"122","author":"Charles","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2014.06.001_bib0505","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1172\/JCI35711","article-title":"NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism","volume":"118","author":"Aliprantis","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2014.06.001_bib0510","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12026-013-8455-2","article-title":"Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly","volume":"57","author":"Serafini","year":"2013","journal-title":"Immunol. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0515","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/jcp.22411","article-title":"T cell suppression by osteoclasts in vitro","volume":"226","author":"Grassi","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.molmed.2014.06.001_bib0520","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.4161\/onci.21990","article-title":"Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction","volume":"1","author":"Danilin","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.molmed.2014.06.001_bib0525","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1158\/0008-5472.CAN-12-2202","article-title":"Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer","volume":"73","author":"Sawant","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0530","doi-asserted-by":"crossref","first-page":"e48871","DOI":"10.1371\/journal.pone.0048871","article-title":"Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+ myeloid-derived suppressor cells","volume":"7","author":"Zhuang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2014.06.001_bib0535","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/blood-2009-11-255026","article-title":"Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells","volume":"116","author":"Li","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2014.06.001_bib0540","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.4049\/jimmunol.0803897","article-title":"Cross-presentation by osteoclasts induces FoxP3 in CD8+ T cells","volume":"182","author":"Kiesel","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2014.06.001_bib0545","doi-asserted-by":"crossref","first-page":"e38199","DOI":"10.1371\/journal.pone.0038199","article-title":"Osteoclast activated FoxP3+ CD8+ T-cells suppress bone resorption in vitro","volume":"7","author":"Buchwald","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2014.06.001_bib0550","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bone.2013.05.024","article-title":"Osteoclast-induced Foxp3+ CD8 T-cells limit bone loss in mice","volume":"56","author":"Buchwald","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2014.06.001_bib0555","doi-asserted-by":"crossref","first-page":"235ra260","DOI":"10.1126\/scitranslmed.3007764","article-title":"T cell costimulation molecules CD80\/86 inhibit osteoclast differentiation by inducing the IDO\/tryptophan pathway","volume":"6","author":"Bozec","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0560","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1136\/ard.2007.080713","article-title":"CTLA-4 directly inhibits osteoclast formation","volume":"67","author":"Axmann","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.molmed.2014.06.001_bib0565","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminoncol.2010.10.007","article-title":"Examining the metastatic niche: targeting the microenvironment","volume":"37","author":"Guise","year":"2010","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.molmed.2014.06.001_bib0570","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0575","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2014.06.001_bib0580","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/nm.1943","article-title":"Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis","volume":"15","author":"Korpal","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0585","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrclinonc.2011.197","article-title":"Denosumab in patients with cancer-a surgical strike against the osteoclast","volume":"9","author":"Brown","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.molmed.2014.06.001_bib0590","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2217\/fon.13.28","article-title":"Zoledronic acid to prevent and treat cancer metastasis: new prospects for an old drug","volume":"9","author":"Young","year":"2013","journal-title":"Future Oncol."},{"key":"10.1016\/j.molmed.2014.06.001_bib0595","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/nm.2489","article-title":"Suppression of bone formation by osteoclastic expression of semaphorin 4D","volume":"17","author":"Negishi-Koga","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2014.06.001_bib0600","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1359\/jbmr.071107","article-title":"A new heterozygous mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts","volume":"23","author":"Del Fattore","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0605","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1359\/jbmr.2000.15.1.103","article-title":"Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover","volume":"15","author":"Angel","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0610","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1359\/jbmr.2003.18.10.1905","article-title":"Tartrate-resistant acid phosphatase knockout mice","volume":"18","author":"Hayman","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0615","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1359\/jbmr.080706","article-title":"Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling","volume":"23","author":"Walker","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2014.06.001_bib0620","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bone.2013.07.023","article-title":"Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors","volume":"57","author":"Ota","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2014.06.001_bib0625","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bone.2012.06.015","article-title":"Afamin secreted from nonresorbing osteoclasts acts as a chemokine for preosteoblasts via the Akt-signaling pathway","volume":"51","author":"Kim","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2014.06.001_bib0630","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cytogfr.2009.10.020","article-title":"BMP-6 and mesenchymal stem cell differentiation","volume":"20","author":"Vukicevic","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.molmed.2014.06.001_bib0635","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/jcb.24537","article-title":"Sclerostin is expressed in osteoclasts from aged mice and reduces osteoclast-mediated stimulation of mineralization","volume":"114","author":"Ota","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.molmed.2014.06.001_bib0640","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1073\/pnas.93.15.7644","article-title":"Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro","volume":"93","author":"Grano","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2014.06.001_bib0645","doi-asserted-by":"crossref","first-page":"e38378","DOI":"10.1371\/journal.pone.0038378","article-title":"Hepatocyte growth factor increases osteopontin expression in human osteoblasts through PI3K, Akt, c-Src, and AP-1 signaling pathway","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2014.06.001_bib0650","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jcb.22406","article-title":"Non-resorbing osteoclasts induce migration and osteogenic differentiation of mesenchymal stem cells","volume":"109","author":"Kreja","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.molmed.2014.06.001_bib0655","doi-asserted-by":"crossref","first-page":"e3537","DOI":"10.1371\/journal.pone.0003537","article-title":"Osteoclasts control osteoblast chemotaxis via PDGF-BB\/PDGF receptor beta signaling","volume":"3","author":"Sanchez-Fernandez","year":"2008","journal-title":"PLOS ONE"},{"key":"10.1016\/j.molmed.2014.06.001_bib0660","first-page":"62","article-title":"PDGF BB purified from osteoclasts acts as osteoblastogenesis inhibitory factor (OBIF)","volume":"13","author":"Kubota","year":"2002","journal-title":"J. Biomol. Tech."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491414000884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491414000884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:49:52Z","timestamp":1716943792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491414000884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":132,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1471491414000884"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2014.06.001","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoclasts: more than \u2018bone eaters\u2019","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2014.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}